K250813 is an FDA 510(k) clearance for the MICROLET®NEXT 2 Lancing Device. This device is classified as a Multiple Use Blood Lancet For Single Patient Use Only (Class II - Special Controls, product code QRL).
Submitted by Ascensia Diabetes Care U.S., Inc. (Parsippany, US). The FDA issued a Cleared decision on May 14, 2025, 58 days after receiving the submission on March 17, 2025.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes..
| 510(k) Number | K250813 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | March 17, 2025 |
| Decision Date | May 14, 2025 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
| Product Code | QRL - Multiple Use Blood Lancet For Single Patient Use Only |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 878.4850 |
| Definition | A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. |